AHSG and metabolic syndrome: However, while a deficiency of fetuin-A increases the risk of cardiovascular mortality in dialysis patients, elevated levels of this protein are also detrimental to health, increasing the risk of cardiovascular diseases, type 2 diabetes, and metabolic syndrome [11-13].